Submitted by: Submitted by atique0214
Views: 117
Words: 1188
Pages: 5
Category: Business and Industry
Date Submitted: 11/09/2014 08:50 AM
BEXIMCO Pharmaceuticals
Projected Amount and Ratios for 2013,2014,2015,2016
Project Cost | | | Sources of Finance | |
Particulars | Taka | | Equity | 18,408,161,859 |
Land and land development | 3,302,101,973 | | Project Loan | 6,181,648,733 |
Building and other civil Works | 5,449,755,930 | | | |
Plant & Machinery | 4,627,921,371 | | Debt/ Equity Ratio | 1/3 |
Furniture | 97,859,648 | |
Office Equipment | 108,248,009 | |
Transportation | 273,680,514 | |
Contingency | 2,342,290,771 | |
Current Asset and Others | 8,387,952,376.00 | |
Total Cost | 24,589,810,592 | |
Projected Sales Revenue, COGS and Operating cost |
| Unit | 2012 | 2013 | 2014 | 2015 | 2016 |
Sales in value- Total | Taka | 9,289,115,284 | 10,682,482,576.60 | 12,284,854,963.09 | 14,127,583,207.55 | 16,246,720,688.69 |
Cost of goods sold- Total | Taka | 4,899,713,857 | 5,634,670,936 | 6,479,871,576 | 7,451,852,312 | 8,569,630,159 |
COGS to Sales | | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 |
Operating Expenses | | | | | | |
Selling, Marketing and Distribution | | 1849296520.00 | 2034226172.00 | 2237648789.20 | 2461413668.12 | 2707555034.93 |
Administartion | | 332225347.00 | 365447881.70 | 401992669.87 | 442191936.86 | 486411130.54 |
Total opearting cost to sales | | 2181521867.00 | 2399674053.70 | 2639641459.07 | 2903605604.98 | 3193966165.47 |
| | | | | | |
Total opearting cost | Taka |...